Greg Stone

Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

Yehuda Carmeli, J. Armstrong, Peter J. Laud et al. · The Lancet Infectious Diseases · 2016 · 409 citations

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

John E. Mazuski, Leanne B. Gasink, J. Armstrong et al. · Clinical Infectious Diseases · 2016 · 385 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Synthesis and Antibacterial Activity of 6-<i>O</i>-Arylbutynyl Ketolides with Improved Activity against Some Key Erythromycin-Resistant Pathogens

Robert F. Keyes, Justin J. Carter, Erika Englund et al. · Journal of Medicinal Chemistry · 2003 · 45 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

Conjunctival microbial flora of clinically normal pigs

Harriet J. Davidson, Donna P. Rogers, Teresa J. Yeary et al. · American Journal of Veterinary Research · 1994 · 36 citations · Full text

Life Sciences, Microbiology, Veterinary Microbiology +17

Nasal colonization by methicillin-resistant coagulase-negative Staphylococcus in community skilled nursing facility patients

Yee-Lean Lee, Thomas C. Cesario, Chi Tran et al. · American Journal of Infection Control · 2000 · 24 citations

Life Sciences, Infectious Diseases, Microbiology +15